Literature DB >> 24604678

Increased catabolic state in spinocerebellar ataxia type 1 patients.

Anja Mähler1, Jochen Steiniger, Matthias Endres, Friedemann Paul, Michael Boschmann, Sarah Doss.   

Abstract

Autosomal dominant spinocerebellar ataxia type 1 (SCA1) is a genetic movement disorder with neuronal loss in the cerebellum, brainstem, and other cerebral regions. The course of SCA1 is accompanied with progressive weight loss and amyotrophia-the causes for that remain, however, unclear. We tested the hypothesis that an imbalance between energy intake and expenditure contributes to weight loss in SCA1 patients. Anthropometric measures, energy intake (food records), and resting (calorimetry) and free-living (accelerometry) energy expenditure were determined in 10 patients with genetically proven SCA1 and 10 healthy controls closely matched for age, sex, and body composition. At rest, energy expenditure per kilogram fat-free mass was 22 % and fat oxidation rate 28 % higher in patients vs. controls indicating an increased catabolic state. Under free-living conditions, total energy expenditure and daily step counts were significantly lower in patients vs. controls. However, most patients were able to maintain energy intake and expenditure in a balanced state. Resting energy expenditure, fat oxidation, and activity energy expenditure per step count are higher, whereas 24-h total energy expenditure is lower in SCA1 patients vs. healthy controls. An altered autonomic nervous system activity, gait ataxia, and a decreased physical activity might contribute to this outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24604678     DOI: 10.1007/s12311-014-0555-6

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  39 in total

1.  A Biometric Study of Human Basal Metabolism.

Authors:  J A Harris; F G Benedict
Journal:  Proc Natl Acad Sci U S A       Date:  1918-12       Impact factor: 11.205

2.  Respiratory quotient is inversely associated with muscle sympathetic nerve activity.

Authors:  S Snitker; P A Tataranni; E Ravussin
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

3.  Autonomic dysfunction in presymptomatic spinocerebellar ataxia type-2.

Authors:  J Montes-Brown; A Machado; M Estévez; C Carricarte; L Velázquez-Pérez
Journal:  Acta Neurol Scand       Date:  2011-02-25       Impact factor: 3.209

4.  Systemic energy homeostasis in Huntington's disease patients.

Authors:  N Ahmad Aziz; Hanno Pijl; Marijke Frölich; Marieke Snel; Trea C M Streefland; Ferdinand Roelfsema; Raymund A C Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-08-14       Impact factor: 10.154

5.  LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance.

Authors:  Michael Boschmann; Stefan Engeli; Cedric Moro; Angelika Luedtke; Frauke Adams; Kerstin Gorzelniak; Gabriele Rahn; Anja Mähler; Kerstin Dobberstein; Antje Krüger; Saskia Schmidt; Simone Spuler; Friedrich C Luft; Steven R Smith; Hartmut H-J Schmidt; Jens Jordan
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

6.  A comparative study of cardiac dysautonomia in autosomal dominant spinocerebellar ataxias and idiopathic sporadic ataxias.

Authors:  M Netravathi; T N Sathyaprabha; K Jayalaxmi; P Datta; M Nirmala; P K Pal
Journal:  Acta Neurol Scand       Date:  2009-09       Impact factor: 3.209

7.  Heart rate variability in type 2 spinocerebellar ataxia.

Authors:  J Montes-Brown; G Sánchez-Cruz; A M García; M E Báez; L Velázquez-Pérez
Journal:  Acta Neurol Scand       Date:  2010-11       Impact factor: 3.209

8.  Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore Longitudinal Study on Aging.

Authors:  J C Seidell; D C Muller; J D Sorkin; R Andres
Journal:  Int J Obes Relat Metab Disord       Date:  1992-09

9.  Spectral analysis of heart rate variability in patients with Machado-Joseph disease.

Authors:  Masato Asahina; Akira Katagiri; Yoshitaka Yamanaka; Yuichi Akaogi; Takeshi Fukushima; Kazuaki Kanai; Satoshi Kuwabara
Journal:  Auton Neurosci       Date:  2010-01-08       Impact factor: 3.145

10.  Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1.

Authors:  Sarah Stricker; Timm Oberwahrenbrock; Hanna Zimmermann; Jan Schroeter; Matthias Endres; Alexander U Brandt; Friedemann Paul
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

View more
  5 in total

1.  Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group.

Authors:  Christiane de M B Almeida Leite; Maria Eliana M Schieferdecker; Caroline Frehner; Renato P Munhoz; Tetsuo Ashizawa; Hélio A G Teive
Journal:  Nutr Neurosci       Date:  2018-05-07       Impact factor: 4.994

2.  Intersegmental coordination patterns are differently affected in Parkinson's disease and cerebellar ataxia.

Authors:  Simon D Israeli-Korn; Avi Barliya; Caroline Paquette; Erika Franzén; Rivka Inzelberg; Fay B Horak; Tamar Flash
Journal:  J Neurophysiol       Date:  2018-11-21       Impact factor: 2.714

3.  Salt-responsive gut commensal modulates TH17 axis and disease.

Authors:  Nicola Wilck; Mariana G Matus; Sean M Kearney; Scott W Olesen; Kristoffer Forslund; Hendrik Bartolomaeus; Stefanie Haase; Anja Mähler; András Balogh; Lajos Markó; Olga Vvedenskaya; Friedrich H Kleiner; Dmitry Tsvetkov; Lars Klug; Paul I Costea; Shinichi Sunagawa; Lisa Maier; Natalia Rakova; Valentin Schatz; Patrick Neubert; Christian Frätzer; Alexander Krannich; Maik Gollasch; Diana A Grohme; Beatriz F Côrte-Real; Roman G Gerlach; Marijana Basic; Athanasios Typas; Chuan Wu; Jens M Titze; Jonathan Jantsch; Michael Boschmann; Ralf Dechend; Markus Kleinewietfeld; Stefan Kempa; Peer Bork; Ralf A Linker; Eric J Alm; Dominik N Müller
Journal:  Nature       Date:  2017-11-15       Impact factor: 49.962

4.  Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease Progression.

Authors:  Alhassane Diallo; Heike Jacobi; Tanja Schmitz-Hübsch; Arron Cook; Robyn Labrum; Alexandra Durr; Alexis Brice; Perrine Charles; Cecilia Marelli; Caterina Mariotti; Lorenzo Nanetti; Marta Panzeri; Maria Rakowicz; Anna Sobanska; Anna Sulek; Ludger Schöls; Holger Hengel; Bela Melegh; Alessandro Filla; Antonella Antenora; Jon Infante; José Berciano; Bart P van de Warrenburg; Dagmar Timmann; Sylvia Boesch; Massimo Pandolfo; Jörg B Schulz; Peter Bauer; Paola Giunti; Laszlo Baliko; Michael H Parkinson; Jun-Suk Kang; Thomas Klockgether; Sophie Tezenas du Montcel
Journal:  Mov Disord Clin Pract       Date:  2017-08-11

Review 5.  From pathways to targets: understanding the mechanisms behind polyglutamine disease.

Authors:  Jonasz Jeremiasz Weber; Anna Sergeevna Sowa; Tina Binder; Jeannette Hübener
Journal:  Biomed Res Int       Date:  2014-09-21       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.